Haverford Financial Services’s Gilead Sciences GILD Stock Holding History

Haverford Financial Services’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-16,950	Closed	-$1.23M	–	68
2021 Q4	$1.23M	Sell	16,950 -93	-0.5%	-$6.41K	0.28%	46
2021 Q3	$1.19M	Sell	17,043 -12	-0.1%	-$843	0.29%	39
2021 Q2	$1.17M	Buy	+17,055	New	+$1.14M	0.29%	42
2017 Q1	–	Sell	-73,142	Closed	-$5.24M	–	59
2016 Q4	$5.24M	Sell	73,142 -1,870	-2%	-$139K	2.21%	24
2016 Q3	$5.93M	Buy	75,012 +28,227	+60%	+$2.29M	2.55%	23
2016 Q2	$3.9M	Sell	46,785 -652	-1%	-$57.9K	1.65%	29
2016 Q1	$4.36M	Buy	+47,437	New	+$4.28M	1.84%	28

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Haverford Financial Services's GILD Position: Q1 2022 in Review

Haverford Financial Services sold out of Gilead Sciences (GILD) in Q1 2022, closing a stake of 16,950 shares — an estimated $1.23M sold.

Haverford Financial Services first reported a position in GILD in Q1 2016 and held it in 7 quarters. The position peaked at $5.93M in Q3 2016. 1,601 funds tracked by Wall St. Rank hold GILD as of Q1 2022.

Haverford Financial Services reported no remaining Gilead Sciences position as of Q1 2022 after selling out during the quarter.
Haverford Financial Services sold 16,950 Gilead Sciences shares in Q1 2022, an estimated $1.23M.
Haverford Financial Services first reported a position in Gilead Sciences in Q1 2016 and held it in 7 quarters.
Haverford Financial Services's Gilead Sciences position peaked at $5.93M in Q3 2016.
1,601 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2022.

Based on Haverford Financial Services's 13F filing for Q1 2022, filed 2 May 2022.